Inaugural Thomas Q. Garvey Public Health Lecture

Date: March 24, 2021
Time: 10:30am – 12:00pm Eastern Time
Location: Online

WEBINAR HANDOUTS

COURSE DESCRIPTION & OVERALL GOAL
This inaugural webinar will be hosted in honor of Dr. Thomas Garvey’s commitment to his patients as a primary care provider and longtime member of the Massachusetts Advisory Committee for the Elimination of TB (MACET). Dr. Garvey was committed to public health advocacy, education and TB elimination. In light of World TB Day, speakers will raise awareness of the social and economic consequences of TB, and provide an overview of global and local TB epidemiology. The keynote speaker will further discuss how policy, economics, and equity play a role in strengthening pandemic response.

AGENDA

WHO SHOULD ATTEND
This conference is open to physicians, nurses, residents, fellows, disease investigators, community health workers, and other public health staff who work in collaboration with TB control and prevention programs.

WHY COURSE IS NEEDED
Tuberculosis rates are expected to rise locally and globally in the near future due to the COVID-19 pandemic creating additional barriers in TB prevention and control efforts. Awareness of local and global TB epidemiology and a strong understanding of the long-term impacts of the COVID-19 pandemic are essential to address TB prevention and control needs in the future. This educational activity will provide TB providers and programs with updates of the local and global status of TB control and discuss opportunities to strengthen pandemic response efforts in the future.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be better able:

  • Explain the economic impact of the COVID-19 pandemic in high burden TB populations.
  • Outline the current state of TB locally and globally, including the impact of the COVID-19 pandemic on prevention and control efforts.
  • Recognize the impact of the COVID-19 pandemic on TB programs and patients globally, and apply this understanding when planning for provision of care in the future.
  • Evaluate intersections of policy, economics, and equity in pandemic response and mitigating tuberculosis.
  • Outline lessons learned from the global response to TB and past pandemics to improve patient care during the COVID-19 pandemic.

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the webinar and complete an evaluation.

CONTINUING EDUCATION INFORMATION
http://jointaccreditation.org/sites/default/files/Jointly%20Accredited%20Provider%20TM.jpgIn support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the Massachusetts Department of Public Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIANS: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES: This activity is awarded 1.5 contact hours (60-minute CH). Nurses should only claim those contact hours actually spent participating in the activity.

CONNECTION DETAILS

Please use the following information to connect to the webinar:

Link to join the webinar:
https://rutgers.webex.com/rutgers/k2/j.php?MTID=t0de7ec48eca50e08cd97a887ca429863
Session number: 120 580 4484
Event password: TB2021

Audio conference information:
Dial-in number: 1-650-429-3300
Access code: 120 580 4485 

Please click the image below to download the calendar invite:

FUNDING DISCLOSURE
Funding for this course was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

FACULTY

Karen R. Jacobson, MD, MPH
Associate Professor of Medicine, Boston University School of Medicine
Assistant Professor of Epidemiology, Boston University School of Public Health
Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
Co-chair, Massachusetts Medical Advisory Committee for the Elimination of TB (MACET)

Edward A. Nardell, MD
Professor of Medicine, Harvard Medical School
Associate Professor, Immunology, Infectious Disease and Environmental Health, Harvard School of Public Health Associate Physician, Brigham and Women's Hospital
Co-chair, Massachusetts Medical Advisory Committee for the Elimination of TB (MACET)

Linda Shipton, MD
Assistant Professor of Medicine, Harvard Medical School Cambridge Health Alliance, Department of Infectious Diseases
TB clinic Director, Cambridge Health Alliance and Cambridge Department of Public Health
Co-Chair, Massachusetts Medical Advisory Committee for the Elimination of TB (MACET)

Cynthia A. Tschampl, PhD
Scientist, The Heller School for Social Policy and Management, Brandeis University
Chair-Elect, Stop TB USA Coordinating Board
Member, Massachusetts Medical Advisory Committee for the Elimination of TB (MACET)

 

 

 

PLANNING COMMITTEE

John Bernardo, MD
Tuberculosis Medical Officer
Division of Global Populations and Infectious Disease Prevention
Bureau of Infectious Disease and Laboratory Sciences
Massachusetts Department of Public Health

Jennifer Cochran, MPH
Director
Division of Global Populations and Infectious Disease Prevention,
Bureau of Infectious Disease and Laboratory Sciences,
Massachusetts Department of Public Health

Rosaura Garcia, CHES®
Health Educator II
Global Tuberculosis Institute

Patricia Iyer, MSN, RN, BC
Director of Disease Investigation and Case Management
Division of Global Populations and Infectious Disease Prevention
Bureau of Infectious Disease and Laboratory Sciences,
Massachusetts Department of Public Health

Anita Khilall, MPH
Program Director, Education and Training
Global Tuberculosis Institute

Edward A. Nardell, MD
Professor, Global Health and Social Medicine Departments, Harvard Medical School
Associate Professor, Immunology, Infectious Disease, and Environmental Health, Harvard School of Public Health,
Associate Physician, Brigham and Women’s Hospital
Co-chair, Massachusetts Medical Advisory Committee for the Elimination of TB (MACET)

Dolly Shen
Tuberculosis Services Coordinator
Division of Global Populations and Infectious Disease Prevention, Massachusetts Department of Public Health

If you have any questions, please contact Rosie Garcia at rg981@njms.rutgers.edu.